Evaluation of Relapse Presence in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

January 1, 2022

Conditions
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis Relapse
Interventions
DIAGNOSTIC_TEST

in-vivo Corneal Confocal Microscopy

All study subjects underwent IVCM (Rostock Cornea Module, Heidelberg Retinal Tomograph III; Heidelberg Engineering, Germany). Before the examination, two drops of topical anesthetic with proparacaine hydrochloride (Alcaine 0.5%, Alcon-Couvreur, Belgium) were applied to both eyes. A carbomer-based gel (Viscotears 0.2%; Dr. Gerhard Mann, Chem.- Pharm. Fabrik, Germany) was used as the coupling agent between the cornea and the applanating cap of IVCM. For correctly positioning the central cornea, all subjects were asked to fixate a determined fixation point and controlled with the device camera. All scans were performed in approximately 5 minutes for each eye by a single experienced ophthalmologist, masked from the subject's disease status.

Trial Locations (1)

34899

Marmara University, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Marmara University

OTHER

NCT05218317 - Evaluation of Relapse Presence in Multiple Sclerosis | Biotech Hunter | Biotech Hunter